tanshinone has been researched along with n-acetyl-4-benzoquinoneimine in 1 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (n-acetyl-4-benzoquinoneimine) | Trials (n-acetyl-4-benzoquinoneimine) | Recent Studies (post-2010) (n-acetyl-4-benzoquinoneimine) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 207 | 5 | 76 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Jiang, X; Li, R; Wang, L; Wang, T; Yang, Y; Zhang, X | 1 |
1 other study(ies) available for tanshinone and n-acetyl-4-benzoquinoneimine
| Article | Year |
|---|---|
Tanshinone IIA attenuates acetaminophen-induced hepatotoxicity through HOTAIR-Nrf2-MRP2/4 signaling pathway.
Topics: Abietanes; Acetaminophen; Analgesics, Non-Narcotic; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Benzoquinones; Chemical and Drug Induced Liver Injury; Imines; Liver; Liver Function Tests; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Multidrug Resistance-Associated Proteins; NF-E2-Related Factor 2; RNA, Long Noncoding; Signal Transduction | 2020 |